Reine Allan 4
4 · Prime Medicine, Inc. · Filed Jan 19, 2024
Insider Transaction Report
Form 4
Reine Allan
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-17+600,000→ 600,000 totalExercise: $6.80Exp: 2034-01-17→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on January 17, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.